Target intelligence / Profile preview

Acrolein and other α,β-unsaturated carbonyl compounds

Molecular classification
Other (reactive small molecule toxicants), Environmental pollutant, Not an enzyme, receptor, transporter, or classical molecular target
01

Overview

Acrolein and other α,β-unsaturated carbonyl compounds are small, electrophilic, unsaturated aldehydes and ketones resulting from environmental exposure (e.g., combustion of organic materials) and endogenous lipid peroxidation during oxidative stress. They are not classical biological targets (such as receptors or enzymes), but rather, are highly reactive toxicants that covalently modify nucleophilic sites (especially cysteine thiols) in proteins and DNA via Michael-type addition. This leads to protein dysfunction, cellular stress, neurotoxicity (nerve terminal damage), inflammation, and in some cases, genotoxicity and carcinogenesis. Because these molecules disrupt many molecular pathways through non-specific covalent modification, they are generally considered harmful reactive species rather than druggable therapeutic targets

Other names
Acroleinα,β-unsaturated aldehydesacrylic aldehydeacrylaldehyde2-propenalpropenaldehydeacrolein-type aldehydesconjugated enalsmethyl vinyl ketone (MVK)4-hydroxy-2-nonenal (HNE)
02

Mechanism of action

Drugs like Mesna work as nucleophilic thiol donors, inactivating acrolein by covalent scavenging (neutralization of Michael acceptors)

03

Biological functions

Covalent modification of proteins (not a normal, physiological function)Protein adduct formation via Michael-type additionDisruption of cellular signaling and structure
04

Disease associations

Neurodegenerative disease (via neurotoxicity)InflammationCancer (as a mutagenic environmental toxicant)Cardiovascular disease (via oxidative stress and vascular injury)Other (respiratory tract injury, hepatic injury, general tissue toxicity)
05

Safety considerations

High systemic toxicity (irritant, neurotoxic, mutagenic, carcinogenic)Severe tissue irritation and systemic organ toxicity at low concentrationsHighly flammable and reactive
06

Interacting drugs

Mesna
07

Biomarkers

Protein thioether adducts in urine or tissues3-hydroxypropyl mercapturic acid (a urinary metabolite of acrolein)Increased protein carbonylation and glutathione depletion

Beyond the preview

Go deeper on Acrolein and other α,β-unsaturated carbonyl compounds.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acrolein and other α,β-unsaturated carbonyl compounds.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call